Need Help?

WES of mCRC xenografts under cetuximab treatment, placebo or after treatment release

Determine if cetuximab treatment selects any pre-existing resistant subclones or if the resistant cells, which in vivo determines residual disease, are driven by plasticity effects not linked to mutations.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001005186 Illumina HiSeq 2500 16